All these arguments lead us to consider the zebrafish model and, in particular, the elnasa12235 mutants as an alternative to the traditionally used mammalian model and as an interesting tool for developing new candidates for the treatment of valvulopathies related to elastin deficiency. The gene discussed is ELN; the disease is hyperinsulinemic hypoglycemia, familial, 4.